You are here

  • Home
  • Archive
  • Volume 56, Issue 3
  • A prospective study of circulating mutant KRAS2 in the serum of patients with colorectal neoplasia: strong prognostic indicator in postoperative follow up

Article info

Article menu

This article has a correction. Please see:

Syndicated article
A prospective study of circulating mutant KRAS2 in the serum of patients with colorectal neoplasia: strong prognostic indicator in postoperative follow up
Free

Authors

  1. Correspondence to:
 Dr B Ryan, Department of Gastroenterology, University Hospital Maastricht, PO Box 5800, 6202AZ, Maastricht, the Netherlands;
 bbryan{at}planet.nl
View Full Text

Citation

Ryan BM, Lefort F, McManus R, et al
A prospective study of circulating mutant KRAS2 in the serum of patients with colorectal neoplasia: strong prognostic indicator in postoperative follow up
Molecular Pathology 2003;56:172-179.

Publication history

  • Accepted April 30, 2002
  • First published June 1, 2003.
Online issue publication 
June 01, 2003

  • .

    Reprinted with Permission from Gut

    Reprinted with Permission from Gut

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Copyright 2003 Journal of Clinical Pathology